Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Buckley

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Pilot and Feasibility Studies|November 12, 2022
Auditory rhythmical cueing to improve gait in community-dwelling stroke survivors (ACTIVATE): a pilot randomised controlled trialLisa Shaw, Patricia McCue, Philip Brown, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 16, 2025
Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in <sup>18</sup>F-flurpiridaz positron emission tomography myocardial perfusion imagingOrit Barrett, Aakash Shanbhag, Ryan Zaid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
Comparison, Agreement, and Significance Cutoffs of <sup>18</sup>F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software PackagesRené R Sevag Packard, Christopher Buckley, C David Cooke, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Beatrice Orso, Mahnaz Shekari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathologyMahnaz Shekari, David Vállez García, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 4, 2021
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuumGemma Salvadó, Marta Milà-Alomà, Mahnaz Shekari, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Utility of 18F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive from Nonobstructive Coronary Artery DiseaseDiana M Lopez, Dan Huck, Sanjay Divakaran, et al.
Circulation. Cardiovascular Imaging|October 9, 2025
Utility of <sup>18</sup>F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery DiseaseDiana M Lopez, Daniel M Huck, Sanjay Divakaran, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Pilot and Feasibility Studies|November 12, 2022
Auditory rhythmical cueing to improve gait in community-dwelling stroke survivors (ACTIVATE): a pilot randomised controlled trialLisa Shaw, Patricia McCue, Philip Brown, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 16, 2025
Incremental diagnostic value of artificial intelligence-derived coronary artery calcium in <sup>18</sup>F-flurpiridaz positron emission tomography myocardial perfusion imagingOrit Barrett, Aakash Shanbhag, Ryan Zaid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2025
Comparison, Agreement, and Significance Cutoffs of <sup>18</sup>F-Flurpiridaz PET Myocardial Blood Flow Quantitation Methods and Software PackagesRené R Sevag Packard, Christopher Buckley, C David Cooke, et al.
EJNMMI Research|November 19, 2017
TSPO imaging using the novel PET ligand [<sup>18</sup>F]GE-180: quantification approaches in patients with multiple sclerosisLena Vomacka, Nathalie Lisa Albert, Simon Lindner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Christopher Buckley, Mark R Battle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumAriane Bollack, Beatrice Orso, Mahnaz Shekari, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathologyMahnaz Shekari, David Vállez García, Lyduine E Collij, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 4, 2021
Cerebral amyloid-β load is associated with neurodegeneration and gliosis: Mediation by p-tau and interactions with risk factors early in the Alzheimer's continuumGemma Salvadó, Marta Milà-Alomà, Mahnaz Shekari, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
Utility of 18F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive from Nonobstructive Coronary Artery DiseaseDiana M Lopez, Dan Huck, Sanjay Divakaran, et al.
Circulation. Cardiovascular Imaging|October 9, 2025
Utility of <sup>18</sup>F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery DiseaseDiana M Lopez, Daniel M Huck, Sanjay Divakaran, et al.
Pageof 9